Arthur Kim, MD

Arthur Kim earned his MD from Harvard Medical School. After his internship and residency at Massachusetts General Hospital and fellowship in Infectious Diseases, he joined the faculty at Harvard Medical School where he is Associate Professor of Medicine. Dr. Kim is the Director of the Viral Hepatitis Clinic within the Division of Infectious Diseases at MGH and focuses his clinical and research interests on special populations with HCV, including those with HIV-1/HCV coinfection and in people who inject drugs. He has made contributions particularly in studies of acute HCV and is currently serving as chair of the Hepatitis Transformative Science Group of the Advancing Clinical Therapeutics Globally network (ACTG, formerly AIDS Clinical Trial Group). Dr. Kim has contributed to several guidelines, having completed a 3-year term as co-chair of the American Association for the Study of Liver Disease (AASLD)/ Infectious Diseases Society of America Guidance for Hepatitis C (available at hcvguidelines.org) during 2016-2018, the NIH COVID-19 guidelines from 2020-2024. He currently serves on the DHHS Antiretroviral and Opportunistic Infection Guidelines, IDSA COVID-19 Treatment Guidelines and AASLD /IDSA HBV guidelines.